Skip to main content
SpringerLink
Log in

Medical Treatment of Dystonia

  • Conference paper
Dyskinesia

Part of the book series: Psychopharmacology Supplementum ((PSYCHOPHARM,volume 2))

Abstract

We review dystonia treatment results since 1981, including our own findings. Anticholinergics are still the most effective drugs, but less than 50% of patients continue with treatment. The authors recommend a combination of an anticholinergic, a benzodiazepine, and another drug (an antidopaminergic, carbamazepine, or fluperlapine) for the treatment of dystonia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Altrocchi PH, Forno LS (1983) Spontaneous oral-facial dyskinesia: Neuropathology of a case. Neurology 33: 802–805

    PubMed  CAS  Google Scholar 

  • Burke R, Fahn S (1983) Double-blind evaluation of trihexyphenidyl in dystonia. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 189–192

    Google Scholar 

  • Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J (1982) Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet 1: 1299

    Article  PubMed  CAS  Google Scholar 

  • Casey DE (1980) Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology 30: 690–695

    PubMed  CAS  Google Scholar 

  • Fahn S (1983a) High-dosage anticholinergic therapy in dystonia. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 177–188

    Google Scholar 

  • Fahn S (1983b) High dosage anticholinergic therapy in dystonia. Neurology 33: 1255–1261

    PubMed  CAS  Google Scholar 

  • Faurbye A, Rasch PJ, Bender Petersen P, Brandborg G, Pakkenberg H (1964) Neurological symptoms in pharmacotherapy of psychosis. Acta Psychiatry Scand 40: 10–27

    Article  CAS  Google Scholar 

  • Fog R, Pakkenberg H (1970) Combined nitoman-pimozide treatment of Huntington’s chorea and other hyperkinetic syndromes. Acta Neurol Scand 46: 249–251

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Albea E, Franch O, Munoz D, Recoy JR (1981) Brueghel’s syndrome, report of a case with postmortem studies. J Neurol Neurosurg Psychiatry 44: 437–440

    Article  PubMed  CAS  Google Scholar 

  • Gollomp SM, Fahn S, Bush R, Recher A, Ilson J (1983) Therapeutic trial in Meige’s syndrome. In: Fahn S, Calne D, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 207–214

    Google Scholar 

  • Jankovic J, Ford J (1983) Blepharospasm and orofacialcervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 13: 402–411

    Article  PubMed  CAS  Google Scholar 

  • Lang AE, Sheehy MP, Marsden CD (1982) Anticholinergics in adult-onset focal dystonia. J Can Sci Neurol 9: 313–319

    CAS  Google Scholar 

  • Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel’s syndrome). J Neurol Neurosurg Psychiatry 37: 1204–1209

    Article  Google Scholar 

  • Marsden CD (1981) Treatment of torsion dystonia. In: Barbeau A (ed) Disorders of movement. MTP Press, Lancaster, pp 81–104

    Google Scholar 

  • Marsden CD, Fahn S (1982) Problems in dyskinesias. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 191–195

    Google Scholar 

  • Marsden CD, Lang AE, Sheehy MP (1983) Pharmacology of cranial dystonia. Neurology 33: 1100–1101

    PubMed  CAS  Google Scholar 

  • Nutt JG, Hammerstad JP, Carter JH, DeGarmo P (1983) Meige’s syndrome: treatment with trihexiphenidyl. Adv Neurol 37: 201–205

    PubMed  CAS  Google Scholar 

  • Obeso JA, Rothwell JC, Lange AE, Marsden CD (1983) Myoclonic dystonia. Neurology 33: 825–830

    PubMed  CAS  Google Scholar 

  • Pakkenberg B, Regeur L, Fog R, Pakkenberg H (1982) Gilles de la Tourette’s syndrom. Ugeskr Laeger 144: 3078–3080

    PubMed  CAS  Google Scholar 

  • Stahl SM, Berger PA (1982) Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias. Neurology 32: 889–892

    PubMed  CAS  Google Scholar 

  • Tanner CM, Glantz RH, Klawans HL (1982) Meige’s disease: acute and chronic cholinergic effects. Neurology 32: 783–784

    PubMed  CAS  Google Scholar 

  • Tolosa ES (1981) Clinical features of Meige’s disease. Arch Neurol 38: 147–151

    PubMed  CAS  Google Scholar 

  • Weiner WJ, Nausieda PA (1982) Meige’s syndrome during long-term dopaminergic therapy in Parkinson’s disease. Arch Neurol 39: 451–452

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Hvidovre University Hospital, DK-2650, Hvidovre, Denmark

    B. Pedersen

Authors
  1. H. Pakkenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Research, Psychiatry and Neurology Services at the Veterans Administration Medical Center, USA

    Daniel E. Casey MD (Clinical Investigator, Associate Professor, Collaborative Scientist) (Clinical Investigator, Associate Professor, Collaborative Scientist)

  2. Departments of Psychiatry and Neurology at the Oregon Health Sciences University, 97207, Portland, OR, USA

    Daniel E. Casey MD (Clinical Investigator, Associate Professor, Collaborative Scientist) (Clinical Investigator, Associate Professor, Collaborative Scientist)

  3. Oregon Regional Primate Research Center, 97006, Beaverton, OR, USA

    Daniel E. Casey MD (Clinical Investigator, Associate Professor, Collaborative Scientist) (Clinical Investigator, Associate Professor, Collaborative Scientist)

  4. Intramural Research Program, National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, National Institute of Health, 20205, Bethesda, MD, USA

    Thomas N. Chase MD (Director) (Director)

  5. H. Lundbeck A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark

    Anne Vibeke Christensen MSc Pharm, DSc (Vice-President, Director of Research) (Vice-President, Director of Research)

  6. Department AEH, Sct. Hans Mental Hospital, DK-4000, Roskilde, Denmark

    Jes Gerlach MD

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Pakkenberg, H., Pedersen, B. (1985). Medical Treatment of Dystonia. In: Casey, D.E., Chase, T.N., Christensen, A.V., Gerlach, J. (eds) Dyskinesia. Psychopharmacology Supplementum, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70140-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70140-5_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70142-9

  • Online ISBN: 978-3-642-70140-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation